CRESCENT BIOPHARMA, INC.
A biotech company developing bispecific antibody therapies to treat solid tumors.
CBIO | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 300 FIFTH AVENUE, 2451 WALTHAM
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Crescent Biopharma, Inc. is a biotechnology company focused on developing and delivering the next wave of cancer therapies. The company's vision is to build a world-leading oncology enterprise by advancing a pipeline of therapies with multiple modalities. Its lead candidate, CR-001, is a proprietary anti-PD-1/anti-VEGF bispecific antibody designed to treat solid tumors. Crescent Biopharma aims to transform cancer treatment and establish a new standard of care for patients by capitalizing on revolutionary shifts in the field. The company is guided by a seasoned leadership team with deep expertise in building innovative biotechnology companies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CRESCENT BIOPHARMA, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CRESCENT BIOPHARMA, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CRESCENT BIOPHARMA, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
